Cargando…
Countering TRAIL Resistance in Melanoma
Melanoma of the skin has become a prime example for demonstrating the success of targeted cancer therapy. Nevertheless, high mortality has remained, mainly related to tumor heterogeneity and inducible therapy resistance. But the development of new therapeutic strategies and combinations has raised h...
Autor principal: | Eberle, Jürgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562618/ https://www.ncbi.nlm.nih.gov/pubmed/31083589 http://dx.doi.org/10.3390/cancers11050656 |
Ejemplares similares
-
Silencing of Mcl-1 overcomes resistance of melanoma cells against TRAIL-armed oncolytic adenovirus by enhancement of apoptosis
por: Tolksdorf, Beatrice, et al.
Publicado: (2021) -
ROS-dependent phosphorylation of Bax by wortmannin sensitizes melanoma cells for TRAIL-induced apoptosis
por: Quast, S-A, et al.
Publicado: (2013) -
General Sensitization of Melanoma Cells for TRAIL-Induced Apoptosis by the Potassium Channel Inhibitor TRAM-34 Depends on Release of SMAC
por: Quast, Sandra-Annika, et al.
Publicado: (2012) -
Sensitization of melanoma cells for TRAIL-induced apoptosis by BMS-345541 correlates with altered phosphorylation and activation of Bax
por: Berger, A, et al.
Publicado: (2013) -
Arbitrary numbers counter fair decisions: trails of markedness in card distribution
por: Schroeder, Philipp A., et al.
Publicado: (2015)